These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 11809115)
1. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome]. Zhao M; Chen X; Chen Y; Liu Z; Liu Y; Lu F; Zhang Y; Wang H Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):528-31. PubMed ID: 11809115 [TBL] [Abstract][Full Text] [Related]
2. Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome. Zhao M; Chen X; Chen Y; Liu Z; Liu Y; Lu F; Zhang Y; Wang H Nephrology (Carlton); 2003 Jun; 8(3):105-9. PubMed ID: 15012724 [TBL] [Abstract][Full Text] [Related]
3. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study. Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147 [TBL] [Abstract][Full Text] [Related]
4. [A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children]. Yi ZW; Wu XC; Xu H; Zhou LJ; Wu YB; Feng SP; Zhou JH; Yang Q; Zhu GH; Liu AM; Wei MJ; Yu L; Zeng ZF Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):575-8. PubMed ID: 18947472 [TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children. Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534 [TBL] [Abstract][Full Text] [Related]
7. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome]. Geng HY; Ji LN; Chen CY; Tu J; Li HR; Bao R; Lin Y Zhonghua Er Ke Za Zhi; 2018 Sep; 56(9):651-656. PubMed ID: 30180402 [No Abstract] [Full Text] [Related]
8. Mycophenolate mofetil treatment in primary glomerular disease: one-year follow-up in steroid dependent and resistant nephrotic syndrome. Tasanarong A; Thitiarchakul S J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S218-27. PubMed ID: 17044475 [TBL] [Abstract][Full Text] [Related]
11. Assessment of mycophenolate mofetil for treatment of frequently relapsing nephrotic syndrome in children. Yi ZW; Dang XQ; He QN; Wu XC; Cao Y; Huang DL; He XJ; Mo SH Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):938-40. PubMed ID: 18182707 [TBL] [Abstract][Full Text] [Related]
12. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome. Gellermann J; Ehrich JH; Querfeld U Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740 [TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Bagga A; Hari P; Moudgil A; Jordan SC Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181 [TBL] [Abstract][Full Text] [Related]
14. Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome. Chan TM; Lin AW; Tang SC; Qian JQ; Lam MF; Ho YW; Tse KC; Chan KW; Lai KN; Tang CS Nephrology (Carlton); 2007 Dec; 12(6):576-81. PubMed ID: 17995584 [TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center. Fujinaga S; Ohtomo Y; Hirano D; Nishizaki N; Someya T; Ohtsuka Y; Kaneko K; Shimizu T Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332 [TBL] [Abstract][Full Text] [Related]
17. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial. Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945 [TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome. Li Z; Duan C; He J; Wu T; Xun M; Zhang Y; Yin Y Pediatr Nephrol; 2010 May; 25(5):883-8. PubMed ID: 19953275 [TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome. Okada M; Sugimoto K; Yagi K; Yanagida H; Tabata N; Takemura T Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300 [TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study. Senthil Nayagam L; Ganguli A; Rathi M; Kohli HS; Gupta KL; Joshi K; Sakhuja V; Jha V Nephrol Dial Transplant; 2008 Jun; 23(6):1926-30. PubMed ID: 17989103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]